Patent · US Active

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

US12030952B2 · kind B2 · utility

1Cited by

97References

10Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Harald Duerr · Starnberg, DE
Sebastian Fenn · Clapham, GB
Ulrich Goepfert · Penzberg, DE
Sabine Imhof-Jung · Planegg, DE
Christian Klein · Iffeldorf, DE
Laurent Lariviere · Ostendorf, DE
Michael Molhoj · Munich, DE
Joerg Thomas Regula · Munich, DE
Petra Rueger · Penzberg, DE
Wolfgang Schaefer · Sankt Augustin, DE

Key dates

Filing date	May 23, 2022
Grant date	Jul 9, 2024
Priority date	—
Expiry date	Sep 21, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Herein are provided bispecific anti-human CD20/human transferrin receptor antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.